Surrey Heartlands

Joint Formulary & PAD

Escitalopram - Generalised Anxiety Disorder (GAD)

You are here : Home > Formulary Search > Escitalopram - Generalised Anxiety Disorder (GAD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
 

Status 2

Green (see narrative)
Formulations :
  • Oral drops
  • Oro-dispersible tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

For use where ordinary tablets are not suitable.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Escitalopram
Indication :
Generalised Anxiety Disorder (GAD)
Group Name :
Keywords :
GAD
Brand Names Include :
Cipralex
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (2)

03 May 17 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
GENERIC Escitaloparn has been considered by the PCN and has been assigned a GREEN traffic light status

NOTE - the branded product, Cipralex, was considered BLACK at the PCN in May 2017.
04 Feb 11 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
APC members concurred that there is a place in therapy for treatment with Escitalopram for GAD

Other Indications

Below are listed other indications that Escitalopram is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Generalised Anxiety Disorder (GAD).